FDA approves Dymicron’s study of cervical artificial disc
The first implantation of the system is anticipated in the fourth quarter of this year.

The first implantation of the system is anticipated in the fourth quarter of this year.
The platform provides real-time visualisation of infectious disease trends using diagnostic test results.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
FDA approves Felix NeuroAI Wristband for essential tremor treatment
Neuralink secures $650m in Series E to advance brain implant technology
Are regulators keeping pace with AI adoption in clinical trials?
AI-enabled medical devices present unique cybersecurity threats